Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL27394412 | 0.98 | TDP1 (0.62) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL720358 | 0.85 | TDP1 (0.79) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL77039 | 0.83 | TDP1 (0.64) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL29655271 | 0.82 | TDP1 (0.62) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL29655008 | 0.81 | TDP1 (0.71) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL27677622 | 0.81 | VCAM1 (0.60) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL721310 | 0.81 | TDP1 (0.71) | TDP1ALDH1A1MEN1POLBKMT2A | |
| SCHEMBL29745239 | 0.80 | TDP1 (0.72) | TDP1ALDH1A1CYP3A4TSHRATM | |
| SCHEMBL216553 | 0.80 | TDP1 (0.72) | TDP1ALDH1A1CYP3A4TSHRATM | |
| SCHEMBL10477444 | 0.79 | LMNA (0.64) | TDP1ALDH1A1MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119931105-A | Polyimide composite flexible film based on magnetron sputtering and preparation method thereof | 圭胜(南通)新材料科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-111018717-A | Method for synthesizing 4-fluoro-2-nitroaniline by using microchannel reactor | 成都艾必克医药科技有限公司 | 2020-04-17 | — | — | CN | claimed |
| US-20180355099-A1 | Fluorinated Benzoxadiazole-Based Donor-Acceptor Polymers for Electronic and Photonic Applications | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2018-12-13 | — | — | US | claimed |
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | claimed |
| CN-1243007-C | Bismuth color reagent of azofluorophosphine-DBF and its synthesis and use | UNIV EAST CHINA NORMAL (CN) | 2006-02-22 | — | — | CN | claimed |
| CN-1206233-C | Synthesis and use of novel thorium color developing reagent metafluoro azo fluorophosphine | UNIV EAST CHINA NORMAL (CN) | 2005-06-15 | — | — | CN | claimed |
| CN-1456565-A | Bismuth color reagent of azofluorophosphine-DBF and its synthesis and use | UNIV HUADONG (CN) | 2003-11-19 | — | — | CN | claimed |
| CN-1450071-A | Synthesis and use of novel thorium color developing reagent metafluoro azo fluorophosphine | UNIV EAST CHINA NORMAL (CN) | 2003-10-22 | — | — | CN | claimed |
| CN-122094953-A | 1, 3-Dihydro-2H-pyrrolo [3,4-c ] quinoline derivatives as cGAS inhibitors for the treatment of inflammatory and/or autoimmune diseases | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260138966-A1 | WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE | UNIV OF MARYLAND BALTIMORE (US) | 2026-05-21 | — | — | US | disclosed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-20260124214-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2026-05-07 | — | — | US | disclosed |
| US-20260034142-A1 | Therapeutic Compounds and Compositions for Treating Social Disorders and Substance Use Disorders | Kinoxis Therapeutics Pty Ltd (AU) | 2026-02-05 | — | — | US | disclosed |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-4263441-A | BENZOXAZOLE DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-04-21 | — | — | US | disclosed |
| US-4167638-A | Process for production of 8-NHR quinolines | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1979-09-11 | — | — | US | disclosed |
| EP-0002030-A1 | Fluorinated benzazole derivatives, method for their preparation and their use as optical brighteners | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-30 | — | — | EP | disclosed |
| US-4138571-A | Nitrophenyl imino propionates | GAF CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4113954-A | PROCESS FOR THE PREPARATION OF 3-ANILINO-5-PYRAZOLONES | GAF CORPORATION (US) | 1978-09-12 | — | — | US | disclosed |
| US-3957860-A | SULFAMIC ACID | CIBA-GEIGY AG (CH) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124214-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | CBR1, NR3C1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | TDP1 1135/4885ALDH1A1 1397/4885MEN1 2710/4885 |
| US-20250361236-A9 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | DGKG, DGKB, DGKK | TDP1 2436/4885ALDH1A1 4095/4885MEN1 4106/4885 |
| US-20180355099-A1 | Fluorinated Benzoxadiazole-Based Donor-Acceptor Polymers for Electronic and Photonic Applications | FTO, PPOX, FOXO3 | TDP1 956/4885ALDH1A1 1862/4885MEN1 3406/4885 |
| US-20260138966-A1 | WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE | CTNNB1, WNT1, CTNND1 | TDP1 4819/4885ALDH1A1 3230/4885MEN1 4746/4885 |
| US-20260034142-A1 | Therapeutic Compounds and Compositions for Treating Social Disorders and Substance Use Disorders | SLC6A3, SLC6A4, SLC6A1 | TDP1 1120/4885ALDH1A1 210/4885MEN1 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.